Showing results (681-690 of 747) with videos related to

Sort By:
Pageof 75
Vaccine|January 25, 2011
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infectionJaap T van Dissel, Darius Soonawala, Simone A Joosten, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2006
Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatmentKonstantin P Lyashchenko, Rena Greenwald, Javan Esfandiari, et al.
Scientific Reports|May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment responseAdam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
The New England Journal of Medicine|October 30, 2019
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent TuberculosisDereck R Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
The Lancet. Respiratory Medicine|December 11, 2020
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trialTracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, et al.
Plos One|July 31, 2009
Signal regulatory protein alpha (SIRPalpha) cells in the adaptive response to ESAT-6/CFP-10 protein of tuberculous mycobacteriaW Ray Waters, Mitchell V Palmer, Brian J Nonnecke, et al.
International Forum of Allergy & Rhinology|May 13, 2024
Patterns of virtual reality and Fitbit wearable activity device use after skull base surgeryVivek C Pandrangi, Ana Araujo, Michelle Buncke, et al.
The Journal of Clinical Investigation|December 3, 2011
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionPhilana Ling Lin, Jes Dietrich, Esterlina Tan, et al.
AIDS Research and Human Retroviruses|May 3, 2013
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-BissauVictor Raúl Gómez Román, Kristoffer Jarlov Jensen, Sanne Skov Jensen, et al.
The Laryngoscope|January 3, 2025
Postoperative Implementation of Virtual Reality and Wearable Devices: Opportunities and ChallengesVivek C Pandrangi, Ana V Araujo, Michelle Buncke, et al.
Pageof 75